Radiopharm Theranostics Ltd (RADX) AI Dilution Summary

Cash was $4,138,074 at 2026-06-30 against estimated monthly burn of $4,398,570. The active funding facility is an ATM with Leerink Partners LLC, authorised to $9,300,000 with $0 sold to date. The most recent capital raised was a public offering that closed 2026-09-17 at $0.0090 per share.